Literature DB >> 12911716

Pseudomyxoma peritonei: the 'controversial' disease.

E Galani1, G M Marx, C B Steer, G Culora, P G Harper.   

Abstract

Pseudomyxoma peritonei (PMP) is a rare disease that is characterized by a large amount of mucinous ascites with peritoneal and omental implants. The etiology of the disease remains unclear. Histologically, two main categories have been described: disseminated peritoneal adenomucinosis (DPAM) and peritoneal mucinous carcinomatosis (PMCA). It is commonly diagnosed incidentally at laparotomy. Most investigators agree that radical surgical debulking and appendectomy are the cornerstone of treatment, but the optimal management of the disease remains controversial. The role of intraoperative and intraperitoneal chemotherapy has been evaluated by a number of authors. The clinical outcomes vary widely between the benign and the malignant forms and between the different treatment modalities. We discuss the pathology, origin, clinical presentation, diagnosis, treatment, and prognosis of PMP.

Entities:  

Mesh:

Year:  2003        PMID: 12911716     DOI: 10.1046/j.1525-1438.2003.13318.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  Multiple Small Bowel Perforations Secondary to Tumor Lysis-a Complication of Pseudomyxoma Peritonei in a Patient Undergoing Intraperitoneal Chemotherapy.

Authors:  Abdul Ahad Rana; Abdullah Rana; Peter Hewett
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.

Authors:  Cristina Semino-Mora; Hui Liu; Thomas McAvoy; Carol Nieroda; Kimberley Studeman; Armando Sardi; Andre Dubois
Journal:  Ann Surg Oncol       Date:  2008-02-26       Impact factor: 5.344

3.  Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix.

Authors:  Lucas Sideris; Andrew Mitchell; Pierre Drolet; Guy Leblanc; Yves E Leclerc; Pierre Dubé
Journal:  Can J Surg       Date:  2009-04       Impact factor: 2.089

4.  Critical alkalosis following intraperitoneal irrigation with sodium bicarbonate in a patient with pseudomyxoma peritonei.

Authors:  Yumiko Shirasawa; Hanayo Orita; Kazuyoshi Ishida; Yasuhiro Morimoto; Mishiya Matsumoto; Takefumi Sakabe
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

5.  Intraductal papillary mucinous carcinoma with atypical manifestations: report of two cases.

Authors:  Seung Eun Lee; Jin-Young Jang; Sung Hoon Yang; Sun-Whe Kim
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

6.  Pseudomyxoma peritonei of 92 Chinese patients: clinical characteristics, pathological classification and prognostic factors.

Authors:  Ai-Tao Guo; Yan-Mi Li; Li-Xin Wei
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

7.  Pseudomyxoma peritonei--a revisit: report of 2 cases and literature review.

Authors:  Chunyanca Li; Rani Kanthan; S C Kanthan
Journal:  World J Surg Oncol       Date:  2006-09-01       Impact factor: 2.754

8.  Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).

Authors:  Chin-Fan Chen; Che-Jen Huang; Wan-Yi Kang; Jan-Sing Hsieh
Journal:  World J Surg Oncol       Date:  2008-11-11       Impact factor: 2.754

9.  Pseudomyxoma peritonei.

Authors:  Maria Homeag; Viorela Enachescu; Luci Elena Pavel; B Zaharia; N Manescu
Journal:  Curr Health Sci J       Date:  2009-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.